Improving Access to Screening, Together
Guardant SCREENS partners with community organizations to advance the early detection of colorectal cancer.
Our Commitment
At Guardant Health, we believe that improving cancer outcomes begins by expanding access to colorectal cancer (CRC) screening. While innovation has transformed what is possible in early cancer detection, too many uninsured and medically underserved individuals continue to face barriers to receiving recommended screening.
That's why we created Guardant SCREENS (Strengthening Community Reach and Engagement to improve Equity, Navigation, and Screening for CRC) — a grants and donation program built to close that gap, community by community. Through the program, eligible organizations can apply to receive donated Shield™ tests or grant funding to enhance outreach, delivery, and access to CRC screening for their uninsured and medically underserved populations.
Strengthening Community Reach: Supporting local organizations that serve the uninsured & medically underserved.
Improving Access to CRC Screening: Reaching populations that have historically gone unscreened.
Advancing Equity: Supporting better health outcomes for those who face barriers to care.
The Need
Lack of access to screening remains one of the biggest barriers to detecting CRC early - and that access gap often falls hardest on uninsured and underserved communities. The data below makes the case for why this matters when it comes to CRC, and why closing that gap can't wait.
A Leading
Cause of Death
CRC remains one of the leading causes of cancer deaths in the U.S.1
The Uninsured
Gap
Nearly 80% of uninsured Americans remain unscreened for CRC.1
A Delayed
Diagnosis
Underserved populations are more likely to be diagnosed at later, less treatable stages.2
A New
Path
Shield offers an opportunity to reduce barriers and bring screening to more uninsured people.
Meaningful Change Happens
Through Trusted Partnerships
Community organizations understand the unique needs of the populations they serve and play a critical role in addressing barriers to CRC screening. By combining their expertise with Guardant's commitment to innovation and access, we can work together to support earlier cancer detection - creating a future where every eligible individual has the opportunity to benefit from life-saving CRC screening.